Impact of the Introduction of a Gastro-intestinal Panel by Polymerase Chain Reaction (PCR).

NCT03551340 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 210

Last updated 2020-10-23

No results posted yet for this study

Summary

Evaluation of the impact of the introduction of multiplex PCR panels on the clinical management of patients with gastroenteritis at the University Hospital of Lausanne, Switzerland.

Conditions

Interventions

DIAGNOSTIC_TEST

Gastro-intestinal panel by PCR

The study will evaluate the change in medical management with the replacement of traditional stool investigations (microscopy and culture) by the new gastrointestinal multiplex PCR panels

Sponsors & Collaborators

  • University of Lausanne Hospitals

    lead OTHER

Principal Investigators

  • Serge de Valliere, MD,MSc · University of Lausanne Hospitals

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-01
Primary Completion
2018-12-31
Completion
2020-03-30

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03551340 on ClinicalTrials.gov